Literature DB >> 7362293

The incidence and causes of death following surgery for nonmalignant biliary tract disease.

C K McSherry, F Glenn.   

Abstract

In the 46-year period from September 1, 1932 to September 1, 1978, 11,808 patients were operated on for nonmalignant biliary tract disease. In 80.1% of these patients, the disease was considered chronic, and in 19.9%, acute inflammation was superimposed on the existing condition. There were 207 postoperative deaths, a mortality rate of 1.7%. Advanced age, acute cholecystitis and common duct stones were the principal determinants of operative mortality. Cholecystectomy for chronic cholecystitis was performed in 7,413 patients with an operative mortality of 0.5%. Choledochotomy in search of residual or recurrent common duct calculi was performed in 341 patients with a mortality of 2.1%. Detailed analysis of the causes of death in 105 patients who died during the years 1962 through 1978 revealed that cardiovascular disease, especially myocardial infarction, was the most frequent cause of death. Liver disease, most commonly cirrhosis, was also a major factor in operative mortality.

Entities:  

Mesh:

Year:  1980        PMID: 7362293      PMCID: PMC1344695          DOI: 10.1097/00000658-198003000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Etiological factors in fatal complications following operations upon the biliary tract.

Authors:  F GLENN; C McSHERRY
Journal:  Ann Surg       Date:  1963-05       Impact factor: 12.969

2.  The causes of death following biliary tract surgery for nonmalignant disease.

Authors:  F GLENN; D M HAYS
Journal:  Surg Gynecol Obstet       Date:  1952-03

3.  The Factors Leading to Death in Operations Upon the Gall-Bladder and Bile-Ducts.

Authors:  G J Heuer
Journal:  Ann Surg       Date:  1934-06       Impact factor: 12.969

4.  Cholesterol gallstone dissolution. Current status.

Authors:  J L Thistle
Journal:  Arch Surg       Date:  1973-12

5.  Endoscopic treatment of biliary-tract diseases. An international study.

Authors:  L Safrany
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

  5 in total
  72 in total

1.  Postoperative bile leakage: endoscopic management.

Authors:  P H Davids; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 2.  Bile leak after laparoscopic cholecystectomy.

Authors:  T Ralph-Edwards; H S Himal
Journal:  Surg Endosc       Date:  1992 Jan-Feb       Impact factor: 4.584

3.  Extracorporeal shock wave lithotripsy of bile duct stones: a single institution experience.

Authors:  E Lindström; K Borch; E P Kullman; H G Tiselius; I Ihse
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

4.  The operative risk factors of cholelithiasis in the elderly.

Authors:  N Shinagawa; K Mashita; J Yura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

5.  Preoperative versus intraoperative endoscopic sphincterotomy for management of common bile duct stones.

Authors:  Ahmed A ElGeidie; Gamal K ElEbidy; Yussef M Naeem
Journal:  Surg Endosc       Date:  2010-09-17       Impact factor: 4.584

6.  Biliary duct stones: percutaneous transhepatic removal.

Authors:  K R Stokes; M E Clouse
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Aug-Sep       Impact factor: 2.740

Review 7.  Biliary concrements: the endoscopic approach.

Authors:  A R Rosseland; M Osnes
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

8.  Choledocholithiasis. Endoscopic sphincterotomy or common bile duct exploration.

Authors:  S C Stain; H Cohen; M Tsuishoysha; A J Donovan
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

9.  Six hundred patients with gallstones.

Authors:  D J Warwick; M H Thompson
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

10.  The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients.

Authors:  C K McSherry; H Ferstenberg; W F Calhoun; E Lahman; M Virshup
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.